Cervical cancer as a priority for prevention in different world regions: An evaluation using years of life lost

The relative importance of cancer of the cervix among several important causes of mortality (from cancer and other diseases) has been evaluated by estimating the years of life lost (YLL) by young and middle‐aged women (25–64 years old) in different regions of the world. The life years were weighted to reflect their importance to the individual and to society. On a global basis, cancer of the cervix is responsible for about 2% of the total (weighted) YLL, fewer than for other causes of mortality in this age group. However, it is the most important cause of YLL in Latin America and the Caribbean. It also makes the largest contribution to YLL from cancer in the populous regions of SubSaharan Africa and South‐Central Asia where the actual risk of loss of life from this cause is higher, although overshadowed by noncancer deaths (from AIDS, TB and maternal conditions). The overall picture is not very sensitive to the age weighting function used. The fact that most of the loss of life is preventable, and that simple technologies have been developed that make this practicable, means that cervical cancer has an even higher profile from the perspective of resource allocation in low income settings. © 2004 Wiley‐Liss, Inc.

[1]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[2]  P. Lewis,et al.  Which of two individuals do you treat when only their ages are different and you can't treat both? , 1989, Journal of medical ethics.

[3]  J. Romeder,et al.  Potential years of life lost between ages 1 and 70: an indicator of premature mortality for health planning. , 1977, International journal of epidemiology.

[4]  C. Murray,et al.  Global burden of disease , 1997, The Lancet.

[5]  N. Day,et al.  TRENDS IN MORTALITY FROM CERVICAL CANCER IN THE NORDIC COUNTRIES: ASSOCIATION WITH ORGANISED SCREENING PROGRAMMES , 1987, The Lancet.

[6]  A. Coale,et al.  Revised regional model life tables at very low levels of mortality. , 1989, Population index.

[7]  M. Johannesson,et al.  A Note on QALYs, Time Tradeoff, and Discounting , 1994, Medical decision making : an international journal of the Society for Medical Decision Making.

[8]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[9]  P. Budetti,et al.  Premature Death in the United States: Years of Life Lost and Health Priorities , 1984, Journal of public health policy.

[10]  W. Haenszel A standardized rate for mortality defined in units of lost years of life. , 1950, American journal of public health and the nation's health.

[11]  P. Cook,et al.  Summarizing indices for comparison of cancer incidence data , 1967, International journal of cancer.

[12]  J. Richardson,et al.  Maximizing health benefits vs egalitarianism: an Australian survey of health issues. , 1995, Social science & medicine.

[13]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[14]  A. Parant [World population prospects]. , 1990, Futuribles.

[15]  C. Dye,et al.  Global tuberculosis control: surveillance planning financing. WHO report 2003. , 2003 .

[16]  Gavin Mooney,et al.  Just Health Care , 1986 .

[17]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[18]  J. Sherris,et al.  Planning appropriate cervical cancer prevention programs. 2nd edition. , 2000 .

[19]  R. Kohn An objective mortality indicator. , 1951, Canadian journal of public health = Revue canadienne de sante publique.

[20]  Partha Dasgupta,et al.  Guidelines for Project Evaluation. , 1972 .

[21]  J. Ferlay,et al.  Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .

[22]  Alan D. Lopez,et al.  Mortality by cause for eight regions of the world: Global Burden of Disease Study , 1997, The Lancet.

[23]  J. Dankert,et al.  PHAGOCYTOSIS IN CHRONIC GRANULOMATOUS DISEASE , 1975, The Lancet.

[24]  Thomas Müller-Bohn,et al.  Cost-Benefit Analysis , 2015 .

[25]  Stephen S Raab,et al.  Cervical cancer screening by simple visual inspection after acetic acid. , 2002, Obstetrics and gynecology.

[26]  M. Dempsey Decline in tuberculosis; the death rate fails to tell the entire story. , 1947, American review of tuberculosis.